Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-22-008033
Filing Date
2022-04-01
Accepted
2022-04-01 16:00:11
Documents
6
Period of Report
2022-05-13

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A atos20220303_pre14a.htm PRE 14A 308801
2 atos20220303_pre14aimg001.jpg GRAPHIC 3759
3 atos20220303_pre14aimg002.jpg GRAPHIC 3195
4 atos20220303_pre14aimg003.jpg GRAPHIC 3759
5 proxy1.jpg GRAPHIC 455974
6 proxy2.jpg GRAPHIC 341707
  Complete submission text file 0001437749-22-008033.txt   1424004
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35610 | Film No.: 22798085
SIC: 2834 Pharmaceutical Preparations